Company news
Xspray Pharma AB news in 2025
Xspray Pharma AB's news releases, calls and decks from 2025, newest first.
Xspray Pharma: FDA accepts New Drug Application for XS003 (nilotinib) for the treatment of CML - PDUFA date set for June 18, 2026
October 21, 2025
Xspray Pharma: FDA accepts New Drug Application for XS003 (nilotinib) for the treatment of CML – PDUFA date set for June 18, 2026
October 21, 2025
Xspray Pharma Submits XS003 to the FDA – The Company’s Second Product Candidate from the HyNap Platform
August 19, 2025
Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds
August 12, 2025